Washington, DC 20006-5349
HELPLINE
This week, mesothelioma clinicians and researchers have come together in Lille, France, for the International Mesothelioma Interest Group‘s biannual meeting known as iMig to discuss…
The American Society for Clinical Oncology’s (ASCO) annual meeting concluded last week in Chicago, IL. As the largest oncology meeting in the world, ASCO is…
Watch the video of Dr. Pingpank as he discusses mesothelioma surgery and treatment at UMPC. We meet today with Dr. James Pingpank of the Hillman…
UPDATE: On March 10, 2023, Merck announced through a press release that its Phase 3 study met its primary endpoint of overall survival which was…
The Peer Reviewed Cancer Research Program (PRCRP) is soliciting input regarding the Quality of Life (QoL) and psychosocial aspects of cancer care (diagnosis/treatment/transition to survivorship…
Dr. Wolf is interviewed by Shannon Sinclair, RN, BSN, OCN, who serves as the patient services director at the Mesothelioma Applied Research Foundation. www.curemeso.org. In…
Conversation with Travis Grotz, MD, surgical oncologist at Mayo Clinic who specializes in the treatment of peritoneal malignancies. Dr. Grotz serves on the Science Advisory…
Separately, chemotherapy and immunotherapy are both approved to treat mesothelioma, and individually they work equally well for those patients with the epithelioid type of disease.…
Watch this episode on YouTube. In this episode of MesoTV, we meet with Joseph Friedberg, MD, FACS, a thoracic surgeon at Temple University Hospital-Main Campus…
A new study just published in the journal Science challenged our collective hope that natural infection by Omicron would convey a degree of immunity that…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
